跳至主要内容
临床试验/IRCT20200427047221N1
IRCT20200427047221N1已完成2 期

Memantine versus pelacebo as an adjunct in the treatment of children with Attention Deficit Hyperactivity Disorder: a double-blind randomized, placebo-controlled study

Zanjan University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 12 years(—)
性别
All

入选标准

  • 6 -12 years old
  • No other psychiatric disorders
  • No mental retardation
  • No neurological disorders
  • Not using other medications

排除标准

  • Concomitant treatment with lamotrigine, amantadine, acetylcysteine, dicyclo-serine
  • Concomitant use of hydrochlorothiazide, triamterene, metformin, cimetidine, ranitidine, quinidine
  • Starting a new psychological intervention thirty days before the start of the study
  • History of non-febrile seizures without a definite etiology
  • Simultaneous kidney or liver disease
  • Urinary-genital disorders that increase urinary pH (infections and RTA)
  • No further referral to the clinic

研究者

相似试验